Mississauga, ON -- (SBWIRE) -- 05/22/2013 -- AllPennyStocks.com Media, Inc. (http://www.AllPennyStocks.com/) announces its latest article titled “Aradigm Corp Shares Rise on Exclusive License Deal with Grifols.”
Companies mentioned in this article include Merck & Co. (NYSE:MRK), AstraZeneca PLC (NYSE:AZN), Aradigm Corp. (OTCBB:ARDM), Zogenix, Inc. (Nasdaq:ZGNX) and Grifols, SA (Nasdaq:GRFS).
Article Excerpt:
Pulmonary diseases, or abnormal conditions that affect the lungs and respiratory tract, vary widely. Some acute obstructive respiratory diseases in the category include asthma and chronic bronchitis while infectious diseases include pneumonia and tuberculosis. Chronic obstructive pulmonary disease, or COPD, is another that is widely publicized on television commercials through the efforts to sell the drugs Singulair, made by Merck & Co. (NYSE:MRK), and Symbicort, manufactured by AstraZeneca PLC (NYSE:AZN).
A junior entrenched in the pulmonary disease industry is Aradigm Corp. (OTCBB:ARDM). The emerging specialty pharmaceutical company has product candidates addressing the treatment of bronchiectasis, cystic fibrosis, inhalation tularemia and anthrax infections, as well as for prevention of respiratory and other diseases in tobacco smokers through smoking cessation.
The full version of this article can be found at:
http://www.allpennystocks.com/aps_us/special-reports/358/aradigm-corp-shares-rise-on-exclusive-license-deal-with-grifols.htm
About AllPennyStocks.com
AllPennyStocks.com is focused on the small-cap / penny stock market and has become a reputable name in the investment community. AllPennyStocks.com runs a Canadian and US site to provide investors in Canada as well as the United States with informative and unique content and information. AllPennyStocks.com runs daily technical penny stocks to watch, has a daily market write-up, provides company spotlights, runs unique most active pages strictly for penny stocks trading on the TSX, TSX Venture, NASDAQ and OTC BB, and much more information for the average investor.
AllPennyStocks.com also runs an email newsletter that aims to uncover stocks that are still under the radar of most investors. Criteria AllPennyStocks.com looks for includes strong revenues, a seasoned management, innovative business plans, among many others. AllPennyStocks.com also looks for companies that announce breaking news, recent 52-week highs/lows, technical breakouts, and other favorable corporate information.
Investors are encouraged to subscribe to the AllPennyStocks.com FREE e-mail newsletter and see what tens of thousands of other investors have already been receiving since 1999. Investors can receive their free newsletter subscription by clicking here: http://www.allpennystocks.com/aps_common/newsletter_free.asp.
Contact
AllPennyStocks.com Media, Inc.
Peter Szafranski -- President
Phone: (905) 361-5680
E-Mail: peter@allpennystocks.com
Websites: http://www.allpennystocks.com / http://www.bullishinvestor.com
Note: AllPennyStocks.com has not received compensation for carrying the above-mentioned company; a full disclaimer can be viewed here: http://www.allpennystocks.com/aps_common/disclaimer.asp.